Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure-Reference-Cited by-同舟云学术

Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure

Published:2003-05-27 Issue:20 Volume:107 Page:2555-2558
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Matsumoto Takehiro¹,Wada Atsuyuki¹,Tsutamoto Takayoshi¹,Ohnishi Masato¹,Isono Takahiro¹,Kinoshita Masahiko¹

Affiliation:

1. From the Department of Cardiovascular and Respiratory Medicine (T.M., A.W., T.T., M.O., M.K.) and Central Research Laboratory (T.I.), Shiga University of Medical Science, Tsukinowa, Seta, Otsu, Japan.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Regulation of the activity of human chymase during storage and release from mast cells: The contributions of inorganic cations, pH, heparin and histamine

2. Activation of paracrine TGF‐β1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase

3. Evidence for a Role of Mast Cells in the Evolution to Congestive Heart Failure

Cited by 175 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relation between cardiac magnetic resonance-assessed interstitial fibrosis and diastolic dysfunction in heart failure due to dilated cardiomyopathy;IJC Heart & Vasculature;2024-08

2. Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine;Cardiovascular Pathology;2024-07

3. Mast cells: a novel therapeutic avenue for cardiovascular diseases?;Cardiovascular Research;2024-04-17

4. Evaluation of Alacepril Administration in Canine Patent Ductus Arteriosus According to Plasma Chymase Activity;Animals;2024-04-02

5. Cardiac fibrogenesis: an immuno-metabolic perspective;Frontiers in Physiology;2024-03-21